Okładka książki National Kidney Foundation's Primer on Kidney Diseases

National Kidney Foundation's Primer on Kidney Diseases

zapowiedź
Nie ma jeszcze oceny, możesz być pierwszym, który ocenił!
autor:
Opracowanie zbiorowe
Wydawca:
Elsevier
ISBN:
9780443261930
EAN:
9780443261930
Oprawa:
Miękka
Format:
11x9mm
Liczba stron:
688
Rok wydania:
2027
wysyłka:
po 18.01.2027
332,38
 zł
Cena detaliczna:  
486,00 zł
Najniższa cena z ostatnich 30 dni: 486,00 zł
Covering every relevant topic in this fast-changing field, National Kidney Foundation's Primer on Kidney Diseases, 9th Edition, remains your #1 source of practical, authoritative information in nephrology. Using a clear, concise, and accessible format, this bestselling guide provides well organized, highly readable guidance for residency, fellowship, clinical practice, and board review. The fully revised Primer brings you up to date with all that’s new in the field, including ongoing clinical research and changing treatment protocols. Offering authoritative coverage of the full breadth of nephrology from world leaders in their field, this joint publication of Elsevier and the National Kidney Foundation is both an essential learning tool for trainees and an easy-to-use, reliable reference for practicing clinicians at the point of care.
  • Provides clear, comprehensive coverage of every aspect of nephrology— from foundational science and clinical evaluation to glomerular disease, systemic disease, AKI, CKD, dialysis, transplantation, pediatrics, pregnancy, and hypertension
  • Presents complex material in a clear, easy-to-understand manner that is both accessible to residents and fellows and comprehensive enough for practicing nephrologists
  • Contains a new chapter on Critical Care Nephrology that equips clinicians with a practical, phenotype‑driven approach to diagnosing and managing AKI in the ICU
  • Covers major advances in treating glomerular diseases, including updated KDIGO guidelines and the rapid growth of precision therapies such as C3 inhibitors, BTK inhibitors, and podocyte‑targeted agents
  • Includes new and expanded coverage of SGLT2 inhibitors, nonsteroidal MRAs, and GLP‑1 receptor agonists for kidney and cardiovascular protection in diabetic and non‑diabetic CKD
  • An eBook version is included with purchase. The eBook allows you to access all of the text, figures, and references, with the ability to search, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish after the publication date

Brak recenzji

x
Uwaga!!!
Ten produkt jest zapowiedzią. Realizacja Twojego zamówienia ulegnie przez to wydłużeniu do czasu premiery tej pozycji. Czy chcesz dodać ten produkt do koszyka?
TAK
NIE
Oczekiwanie na odpowiedź
Dodano produkt do koszyka
Kontynuuj zakupy
Przejdź do koszyka
Oczekiwanie na odpowiedź
Wybierz wariant produktu
Dodaj do koszyka
Anuluj